BioMark Diagnostics's total assets for Q2 2026 were C$1.88M, a decrease of -29.34% from the previous quarter. TSE:BUX total liabilities were C$1.01M for the fiscal quarter, a -23.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.